Safinamide: A Review in Parkinson’s Disease-Reference-Cited by-同舟云学术

Safinamide: A Review in Parkinson’s Disease

Published:2017-01-21 Issue:2 Volume:31 Page:169-176
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Blair Hannah A.,Dhillon Sohita

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

http://link.springer.com/content/pdf/10.1007/s40263-017-0408-1.pdf

Reference35 articles.

1. Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670–83.

2. Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.

3. National Institute for Health and Care Excellence. Parkinson’s disease in over 20s: diagnosis and management. 2009. http://www.nice.org.uk . Accessed 9 Jan 2017.

4. Deeks ED. Safinamide: first global approval. Drugs. 2015;75(6):705–11.

5. Sprenger F, Poewe W. Management of motor and non-motor symptoms in Parkinson’s disease. CNS Drugs. 2013;27(4):259–72.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Monoamine Oxidases by Pyridazinobenzylpiperidine Derivatives;Molecules;2024-06-28

2. A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in mdx Mice;Antioxidants;2024-05-21

3. Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice;Neurología (English Edition);2024-05

4. Beyond expectations: safinamide’s unprecedented neuroprotective impact on acute spinal cord injury;European Journal of Trauma and Emergency Surgery;2024-04-11

5. Recent Trends in Nanomaterial Based Electrochemical Sensors for Drug Detection: Considering Green Assessment;Current Topics in Medicinal Chemistry;2024-04